A new Turkish study has raised concerns that Pfizer-BioNTech's COVID-19 vaccine may have subtle but serious side effects on the cornea. The research examined changes in the corneas of at least 64 patients before and after receiving both doses of the vaccine.
According to the scientists involved in the study published in the journal Ophthalmic Epidemiology, even though no immediate vision loss was reported, the vaccine led to thicker corneas, a reduced number of endothelial cells, and structural changes that could affect eye health over time.
The Daily Mail reported the changes in the eyes suggest the Pfizer vaccine may temporarily weaken the endothelium, even though patients did not suffer clear vision issues when the study was being conducted. Scientists said that for those with healthy eyes, these small changes likely may not affect vision right away. However, they may lead to corneal swelling or blurry vision, especially in those with pre-existing eye issues or those who have had a corneal transplant.
Researchers found that the average thickness of the cornea increased from 528 to 542 micrometres after two Pfizer doses, which is around a rise of 2 per cent. The endothelial cell count, which is responsible for keeping the cornea clear, dropped by about 8 per cent, from 2,597 to 2,378 cells per square millimetre.
Scientists urge caution
According to the study, which analysed the eye health with the help of Sirius corneal topography and Tomey EM-4000 specular microscopy, there is no need to halt the vaccination efforts. Scientists have rather called for ongoing monitoring of corneal health in those who already battle vulnerabilities in their eyes.
The researchers have also emphasised that the changes observed can be temporary responses to stress or inflammation that may resolve over time. Still, they warned that "the endothelium should be closely monitored in those with a low endothelial count or who have had a corneal graft", especially if future studies confirm long-term damage.
The Daily Mail said it also adds to existing concerns over rare side effects of mRNA vaccines, which include myocarditis and pericarditis, especially among younger men. The researchers plan to continue tracking participants to determine if these early corneal changes progress or stabilize over time.
Healthy endothelial cells are usually shaped like hexagons, which allows them to fit together tightly, like a honeycomb. Although the two per cent drop was not a direct sign of damage, it did suggest to the team that the cells may be reacting to some sort of stress over a significant period of time, like two months to three months.
Researchers also said their results showed evidence that the changes had a high likelihood of being directly linked to taking the vaccine, meaning it was not just a random anomaly in the testing. If the signs of stress and inflammation drop off shortly after receiving the Pfizer shot, the impact of these minor changes would not be overly harmful.
News
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
